We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Microfluidics Enables Reliable siRNA Drug Delivery for Inflammatory Diseases and Tumor Targeting

Product News   May 27, 2020

 
Microfluidics Enables Reliable siRNA Drug Delivery for Inflammatory Diseases and Tumor Targeting
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Aptamer Group Extends Collaboration With AstraZeneca To Explore Next-Generation Drug Delivery Approaches

Product News

Aptamer Group has announced the extension of their current agreement with AstraZeneca. This agreement will further the existing collaboration to evaluate the potential of using Optimer-based strategies to target renal cells and explore the feasibility of developing next-generation drug delivery vehicles, Optimer-drug conjugates.

READ MORE

Vivan Therapeutics Joins Repositive Cancer Model Network

Product News

Repositive has announced that Vivan Therapeutics will be the next company to join its global network of cancer model partners. With this new partnership, Repositive is expanding its personalized medicine capabilities to support more biopharma customers in their oncology drug development programs.

READ MORE

Liquid Crystal Sensor Offers Breakthrough for Rapid COVID-19 Diagnostic Test

Product News

Researchers have designed a liquid crystal (LC) based diagnostic kit and a smartphone-based application to enable automatic detection of SARS-CoV-2 ssRNA, which could be used for reliable self-test of SARS-CoV-2 at home without the need for complex equipment or procedures.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE